Why are two directors retiring from the IDEXX Board?

Two directors, Mr. Thomas Craig and Dr. Barry C. Johnson, are retiring. Mr. Craig is retiring voluntarily at the end of his term, with no reported disagreements with the company. Dr. Johnson is retiring because he has reached the mandatory retirement age of 73, as outlined in the company's Corporate Governance Guidelines.

When will these director retirements be effective?

The retirements of Mr. Craig and Dr. Johnson will be effective immediately following the expiration of their terms at the Company's 2017 Annual Meeting of Stockholders, which is scheduled to be held on May 3, 2017.

Will the reduction in board size impact the company's operations?

The reduction in board size from ten to eight members is a consequence of the retirements and is in accordance with the company's bylaws. The company has not indicated that this change will have a negative impact on its operations, policies, or practices. Both retirements were planned events and do not stem from any disagreements.

Does this filing indicate any concerns about the company's financial health or strategy?

No, this filing specifically pertains to changes in board composition due to director retirements. The reasons cited for retirement are voluntary departure and reaching a mandatory age limit, with no mention of disagreements related to the company's operations, policies, or practices. Therefore, it does not suggest any concerns about the company's financial health or strategy.

IDXX 8-K: Leadership Changes

Summary

This 8-K filing from IDEXX LABORATORIES, INC. (IDXX) reports on the upcoming retirements of two Class II directors, Mr. Thomas Craig and Dr. Barry C. Johnson, effective after the company's 2017 Annual Meeting of Stockholders on May 3, 2017. Mr. Craig's retirement is voluntary, with no stated disagreements with the company. Dr. Johnson's retirement is due to reaching the mandatory retirement age of 73, as per the company's Corporate Governance Guidelines. Following these retirements, the Board of Directors' size will be reduced from ten to eight members. This change will also adjust the composition of Class II and Class III directors. The company expresses gratitude for the service of both retiring directors. These changes, while impacting board composition, do not indicate any operational issues or disagreements with the company's policies.

Key Highlights

1Two Class II Directors, Thomas Craig and Barry C. Johnson, will retire from the Board.
2Retirements are effective after the 2017 Annual Meeting of Stockholders on May 3, 2017.
3Mr. Craig's retirement is voluntary and not due to any disagreement with the company.
4Dr. Johnson's retirement is due to reaching the mandatory retirement age of 73.
5The size of the Board of Directors will be reduced from ten to eight members.
6The composition of Class II and Class III directors will be adjusted.
7The company thanked both directors for their service.

IDEXX LABORATORIES INC /DE 8-K Report, Executive Changes (Feb 21, 2017)

Summary

Key Highlights

Frequently Asked Questions